MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Zomorph 100mg modified-release capsules (Ethypharm UK Ltd)

Explore other Morphine formulations Explore other Morphine 100mg modified-release capsules suppliers

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Etypharm product.

Use with caution

Zomorph 10mg modified-release capsules (Ethypharm UK Ltd)

Explore other Morphine formulations Explore other Morphine 10mg modified-release capsules suppliers

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Ethypharm product.

Use with caution

Zomorph 200mg modified-release capsules (Ethypharm UK Ltd)

Explore other Morphine formulations Explore other Morphine 200mg modified-release capsules suppliers

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatability recommendation derived from Ethypharm and Napp Pharmaceuticals products.

Use with caution

Zomorph 30mg modified-release capsules (Ethypharm UK Ltd)

Explore other Morphine formulations Explore other Morphine 30mg modified-release capsules suppliers

Stability Notes

Protect from light. Airtight container.

Provenance

Compatibility recommendation derived from Etypharm and Napp Pharmaceuticals products.

Use with caution

Zomorph 60mg modified-release capsules (Ethypharm UK Ltd)

Explore other Morphine formulations Explore other Morphine 60mg modified-release capsules suppliers

Stability Notes

Protect from light. Airtight container. Protect from heat.

Provenance

Compatibility recommendation derived from Etypharm and Napp Pharmaceuticals products.

Use with caution

Zonegran 100mg capsules (Advanz Pharma)

Explore other Zonisamide formulations Explore other Zonisamide 100mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 100mg capsules (Advanz Pharma).

Use with caution

Zonegran 100mg capsules (CST Pharma Ltd)

Explore other Zonisamide formulations Explore other Zonisamide 100mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 100mg capsules (Advanz Pharma).

Use with caution

Zonegran 100mg capsules (Sigma Pharmaceuticals Plc)

Explore other Zonisamide formulations Explore other Zonisamide 100mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 100mg capsules (Advanz Pharma).

Use with caution

Zonegran 25mg capsules (Advanz Pharma)

Explore other Zonisamide formulations Explore other Zonisamide 25mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 25mg capsules (Advanz Pharma).

Use with caution

Zonegran 25mg capsules (CST Pharma Ltd)

Explore other Zonisamide formulations Explore other Zonisamide 25mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 25mg capsules (Advanz Pharma).

Use with caution

Zonegran 25mg capsules (Sigma Pharmaceuticals Plc)

Explore other Zonisamide formulations Explore other Zonisamide 25mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 25mg capsules (Advanz Pharma).

Use with caution

Zonegran 50mg capsules (Advanz Pharma)

Explore other Zonisamide formulations Explore other Zonisamide 50mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 50mg capsules (Advanz Pharma).

Use with caution

Zonegran 50mg capsules (CST Pharma Ltd)

Explore other Zonisamide formulations Explore other Zonisamide 50mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 50mg capsules (Advanz Pharma).

Use with caution

Zonegran 50mg capsules (Necessity Supplies Ltd)

Explore other Zonisamide formulations Explore other Zonisamide 50mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 50mg capsules (Advanz Pharma).

Use with caution

Zonisamide 100mg capsules (A A H Pharmaceuticals Ltd)

Explore other Zonisamide formulations Explore other Zonisamide 100mg capsules suppliers

Stability Notes

Store in an airtight container. Protect from light.

Provenance

This compatibility recommendation is derived from Zonegran 100mg capsules (Advanz Pharma).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.